Iron deficiency anemia can occur secondary to IBD. A new clinical trial demonstrates that ferric carboxymaltose is more cost-effective, convenient and efficacious than iron sucrose for treating iron deficiency anemia in patients with IBD, an innovation that could make anemia treatment easier for clinicians, patients and health-care providers alike.
- Fernando Gomollón
- Javier P. Gisbert